Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Hilleman

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Pharmacotherapy|October 30, 2007
Fibrinolytic agents for the management of ST-segment elevation myocardial infarctionDaniel E Hilleman, James P Tsikouris, A Allen Seals, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2006
Reteplase: a review of its use in the management of thrombotic occlusive disordersDene Simpson, M Asif A Siddiqui, Lesley J Scott, et al.
Critical Care Medicine|March 8, 2006
Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patientsGreet Van den Berghe, Pieter J Wouters, Katrien Kesteloot, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|October 7, 2025
Drug Interactions With Excessive Daytime Sleepiness TreatmentsStanley V Thomas, Mark A Malesker, Daniel E Hilleman, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 6, 2008
Prevalence, treatment, and control of hypertension in residents of skilled nursing facilitiesKelli L Coover, Ann Ryan-Haddad, Michele A Faulkner, et al.
Pharmacotherapy|April 22, 2004
Fingernail clubbing and chromonychia associated with the use of angiotensin II receptor blockersKathleen A Packard, Amy J Arouni, Daniel E Hilleman, et al.
Current Medical Research and Opinion|September 19, 2003
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgeryDaniel E Hilleman, Antonio P Reyes, Aryan N Mooss, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Nesiritide for heart failure: impact on costs and complicationsClaire B Hunter, Francis Ndemo, Thomas L Lenz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2022
Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazideKhalid Bashir, Tammy Burns, Samuel J Pirruccello, et al.
The American Journal of Emergency Medicine|September 13, 2011
A systematic review of nicardipine vs labetalol for the management of hypertensive crisesW Frank Peacock, Daniel E Hilleman, Phillip D Levy, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Pharmacotherapy|October 30, 2007
Fibrinolytic agents for the management of ST-segment elevation myocardial infarctionDaniel E Hilleman, James P Tsikouris, A Allen Seals, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 18, 2006
Reteplase: a review of its use in the management of thrombotic occlusive disordersDene Simpson, M Asif A Siddiqui, Lesley J Scott, et al.
Critical Care Medicine|March 8, 2006
Analysis of healthcare resource utilization with intensive insulin therapy in critically ill patientsGreet Van den Berghe, Pieter J Wouters, Katrien Kesteloot, et al.
The Journal of Pharmacy Technology : Jpt : Official Publication of the Association of Pharmacy Technicians|October 7, 2025
Drug Interactions With Excessive Daytime Sleepiness TreatmentsStanley V Thomas, Mark A Malesker, Daniel E Hilleman, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 6, 2008
Prevalence, treatment, and control of hypertension in residents of skilled nursing facilitiesKelli L Coover, Ann Ryan-Haddad, Michele A Faulkner, et al.
Pharmacotherapy|April 22, 2004
Fingernail clubbing and chromonychia associated with the use of angiotensin II receptor blockersKathleen A Packard, Amy J Arouni, Daniel E Hilleman, et al.
Current Medical Research and Opinion|September 19, 2003
Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgeryDaniel E Hilleman, Antonio P Reyes, Aryan N Mooss, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Nesiritide for heart failure: impact on costs and complicationsClaire B Hunter, Francis Ndemo, Thomas L Lenz, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2022
Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazideKhalid Bashir, Tammy Burns, Samuel J Pirruccello, et al.
The American Journal of Emergency Medicine|September 13, 2011
A systematic review of nicardipine vs labetalol for the management of hypertensive crisesW Frank Peacock, Daniel E Hilleman, Phillip D Levy, et al.
Pageof 7